| Identifiers | ||
| Product Name | IGF-I, human recombinant | |
| Catalogue No. | CM726204 | |
| Description | 20 mg. BioVision’s recombinant human IGF-I is a N-terminus modified IGF-I which shows equivalent or better potency than Long R3 human IGF-I as demonstrated in bioactivity assay. The recombinant IGF-I was produced from E. coli using Animal Origin Free (AOF | |
| Application | 20 mg. BioVision’s recombinant human IGF-I is a N-terminus modified IGF-I which shows equivalent or better potency than Long R3 human IGF-I as demonstrated in bioactivity assay. The recombinant IGF-I was produced from E. coli using Animal Origin Free (AOF) components and suitable for research use and further manufacture in bioproduction. | |
| MW | 7.6 kDa | |
| Source Antibody | E. coli | |
| Storage Condition | -20°C | |
| Brand | Packing | Pricing | Quote request |
| IL | 20 mg | Inquiry | Ask Quote |
Advanced
Technology & Industrial Co., Ltd. all rights reserved |